Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.413 USD | -1.58% | -20.51% | -42.72% |
Jan. 31 | Transcript : Regis Corporation, Q2 2024 Earnings Call, Jan 31, 2024 | |
Jan. 31 | Regis Corporation Provides Strategic Review Update | CI |
Financials (USD)
Sales 2022 | 276M | Sales 2023 | 233M | Capitalization | 50.58M |
---|---|---|---|---|---|
Net income 2022 | -85M | Net income 2023 | -7M | EV / Sales 2022 | 2.62 x |
Net Debt 2022 | 675M | Net Debt 2023 | 541M | EV / Sales 2023 | 2.54 x |
P/E ratio 2022 |
-0.38
x | P/E ratio 2023 |
-6.95
x | Employees | 397 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 87.58% |
Latest transcript on Regis Corporation
1 day | -3.51% | ||
1 week | -21.43% | ||
Current month | -26.67% | ||
1 month | -28.01% | ||
3 months | -41.49% | ||
6 months | -54.24% | ||
Current year | -41.80% |
Managers | Title | Age | Since |
---|---|---|---|
Matthew Doctor
CEO | Chief Executive Officer | 37 | 21-01-31 |
Kersten Zupfer
DFI | Director of Finance/CFO | 49 | 06-12-31 |
Jim Lain
COO | Chief Operating Officer | 60 | 13-11-10 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Mansbach
BRD | Director/Board Member | 56 | 21-06-13 |
Margaret Rhoades
BRD | Director/Board Member | 79 | 15-10-19 |
Michael Merriman
BRD | Director/Board Member | 67 | 11-10-26 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 5.413 | -1.58% | 7 513 |
24-04-18 | 5.5 | -3.51% | 27,330 |
24-04-17 | 5.7 | -3.55% | 13,703 |
24-04-16 | 5.91 | -1.66% | 4,792 |
24-04-15 | 6.01 | -11.75% | 35,190 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.80% | 12.54M | |
-16.85% | 549M | |
+32.85% | 435M | |
-27.58% | 395M | |
+12.93% | 304M | |
-31.61% | 188M | |
-25.93% | 96.42M | |
-3.45% | 67.93M | |
0.00% | 61.81M | |
-26.23% | 61.83M |
- Stock Market
- Equities
- RGS Stock